SLC22A2 and in situ carcinoma: Interestingly, MDA-MB-468 (IC50 = 0.39 μM) demonstrated higher sensitivity towards CIS as compared to Huh7 (IC50 = 1.96 μM) by ~5-fold which could be explained, at least partially, due to higher OCT2 expression levels in the former as compared to the latter.